The NATNAT project is assessing the feasibility and acceptability of complementary vector control approaches in PNG communities and the health system. These tools include residual spraying, spatial emanators, and larval source management.🔗 link.springer.com/article/10.1...

The 2026 Annual Meeting will bring together researchers for two days of knowledge sharing, collaboration, and capacity building, and will be delivered in conjunction with the Malaria Synergy Program (MSP). Secure your spot now🔗 events.humanitix.com/acreme-and-m...

Volatile pyrethroid spatial emanators (SEs) release active ingredients that deter or kill mosquitoes, and 2 SE products have recently been World Health Organization pre-qualified for malaria vector control. academic.oup.com/jid/advance-...

Stakeholder perceptions of these risks may significantly influence the acceptability and uptake of these regimens. Understanding these perceptions is essential for #policymakers to design effective communication and implementation strategies of novel radical cure strategies. 🔗 lnkd.in/evddyiha

The PAVE SCOPE research was a collaborative program of implementation research across Indonesia/PNG. The evidence has directly informed a change in the treatment guidelines in both countries and MOH are now moving ahead - Professor Leanne Robinson lnkd.in/gTMeCmhR

Antimalarial resistance is one of the greatest threats to malaria elimination🦟 This study reveals a potential previously unconsidered antimalarial resistance mechanism for P. falciparum and provides an assay for surveillance in other populations. 🔗 www.biorxiv.org/content/10.6...

Join us for the next webinar featuring Dr Shazia Ruybal-Pesántez, hosted by Prof Sarah Auburn on Thurs 23 July 2pm-3pm AEDT. Understanding Plasmodium vivax resurgence dynamics by integrating genetics and transmission modelling 🔗Register now: lnkd.in/gnWrnkXy

Our PDS is designed to support researchers and build capacity across the Asia-Pacific region. 🔹 Grant Application Support 🔹 Shadowing Opportunities 🔹 Pitch Presentation Coaching 🔹 Peer Learning and Student Supervision 🔹 Regional Hub Training 📩 acreme.edu.au/what-we-do/o...

The emergence of artemisinin-resistant P.falciparum threatens the utility of the current first-line ACTs. Alternatives to artemisinins are urgently required to progress efforts toward reducing malaria morbidity and mortality. Read the latest findings on MMV367 👉 www.science.org/doi/10.1126/...

To understand the risks and benefits of different primaquine dosing regimens for P. vivax malaria in Ethiopia, researchers undertook a systematic review and individual patient data meta-analysis. Read the latest findings: link.springer.com/article/10.1...

The ACREME Regional Hub Travel and Training Grant is now available, providing up to $7,500AUD to support malaria researchers across the Asia-Pacific region ✈️ 📅 Applications close on 24 July 2026. 👉 Learn more: acreme.edu.au/grants/trave...

Congrats to Prof Jennifer Flegg on being elected as a Fellow of The Australian Academy of Science👏🥂She joins 28 outstanding scientists recognised this year for their exceptional contributions to fundamental discovery, translational research, and the commercial application of science @science.org.au

Applications for ACREME’s 2026 Training and Travel Grants are still open. Applications are welcome for anticipated travel and training activities taking place throughout the 2026 calendar year. 🔗https://acreme.edu.au/grants/travel-and-training-grants/

The EFFORT clinical trial was conducted in four countries to evaluate the safety and effectiveness of high-dose primaquine and single-dose tafenoquine compared with the standard 14-day low-dose primaquine regimen for the radical cure of patients with P.vivax malaria lnkd.in/gM5p5d26

The 2026 ACREME Seed Grants are now accepting applications, supporting pilot projects that align with the ACREME MASTER-MAP research themes acreme.edu.au/grants/seed-...

New findings reveal promising correlates of protection for the RTS,S malaria vaccine and new insights to inform the development of next-generation malaria vaccines. #malaria #vaccines @burnetinstitute.bsky.social @acreme.bsky.social doi.org/10.1371/jour...

New findings reveal promising correlates of protection for the RTS,S #malaria #vaccine and new insights to inform the development of next-generation malaria vaccines. @burnetinstitute.bsky.social @acreme.bsky.social journals.plos.org/plosmedicine...

This publication highlights the use of regional high-resolution genetic data to enhance monitoring of transmission intensity and cross-border importations. academic.oup.com/jid/advance-...

In this study, researchers aimed to examine how genetic variation in P vivax affects the utility of these markers and whether redesigned antigens could improve performance. 🔗 : www.sciencedirect.com/science/arti...

These findings reveal promising new correlates of protection for RTS,S and new insights to inform the development of next-generation malaria vaccines. 🔗 journals.plos.org/plosmedicine...

The ACREME team took some well-earned time out in Bangkok to enjoy a relaxed dinner during the APMEN Joint Working Group Meeting. Sometimes the best collaboration happens over good food and even better company 🤝🌏 #Collaboration #GlobalHealth #Bangkok #Malaria #Network #GlobalCollaboration

Photos from the APMEN Joint Working Group meeting in Bangkok 🦟Great to see @kthriemer.bsky.social & Stephan Karl sharing their insights and contributing to important discussions on malaria elimination across the region. 📷 : Win Han Oo #MalariaElimination #GlobalHealth #EndMalaria

Professor Leanne Robinson of @burnetinstitute.bsky.social recently spoke with Madlen Luckner (Nature Communications), reflecting on her work toward malaria elimination and the evolving challenges and opportunities in the field. Read the full interview: www.nature.com/articles/s41...

This study aimed to evaluate the 7-day low-dose primaquine regimen in G6PD-normal patients with uncomplicated P. vivax and/or P. falciparum malaria in the pre-elimination context of Nepal. 🔗 onlinelibrary.wiley.com/doi/10.1111/...

ACREME Investigators will attend the upcoming APMEN Joint Working Groups Meeting in Bangkok, next week ✈️Held under the theme “One Network, Integrated Solutions: Driving a Malaria-Free Asia Pacific,” the meeting will bring together national malaria programs and key partners.

Join ACREME Investigator, Prof Alyssa Barry as World Malaria Day approaches, for a preview of research featured at the upcoming World Malaria Day Seminar 2026. 📅 Tuesday, 21 April at 10am 📍 Lecture Theatre, Health Education and Research Building (HERB) + Zoom 👉 Register here: lnkd.in/gQmxX7DZ

"These exciting results open new avenues for developing P. vivax vaccines to combat the global malaria burden and support the path to elimination." - Professor James Beeson 👉https://shorturl.at/hhaNI

We’re delighted to welcome Edwin Sutanto as our newest PhD student. His research focuses on investigating drug resistance in Plasmodium falciparum in Papua, Indonesia using advanced molecular approaches. Read more about his project: acreme.edu.au/welcome-to-a...

Despite a largely subsidised health system, patients and families face other medical, travel and indirect costs when seeking care for febrile illnesses. These costs need consideration when designing malaria control policies🔗 pubmed.ncbi.nlm.nih.gov/41887663/

These awards support ACREME-affiliated PhD students, Postdoctoral Researchers, and Research Assistants/Officers to take part in valuable opportunities such as training workshops, laboratory exchanges, and field-based training. 🔗https://lnkd.in/giYcU-9g

A reminder that the 2026 ACREME Seed Grants are now open 🎉This is a great opportunity to secure funding for projects aligned with the ACREME research themes. Grants of up to $25K are available. 🔗 acreme.edu.au/grants/seed-...

Are you submitting a grant application soon? 🤔 ACREME's Professional Development Scheme includes Grant Application Support, a dedicated initiative designed to give your application the best possible chance. 🔗 acreme.edu.au/what-we-do/o...

Congrats to Dr @cassidyseyoum.bsky.social on being appointed the 2026 Annual Meeting Organiser👏 The role will coordinate the planning and delivery of our Annual Meeting, bringing together researchers across our network. Please join us in congratulating Sarah 🙌

Women in malaria-endemic and low-resource settings are disproportionately affected by malaria, yet they remain underrepresented in research leadership and decision-making. Learn more about how ACREME is recognising and supporting women in malaria research: 🦟 acreme.edu.au/internationa... #IWD2026

Join us for the Developing New Vaccines Symposium 2026 on Tuesday 24 March in Melbourne. A one-day event bringing together leading researchers and partners to explore the latest advances in vaccine discovery and development.🎟️ events.humanitix.com/developing-n...

ACREME was proud to see students, Kaitlin Pekin, Pailene Lim and Janani Karunarathne contribute to the 16th Victorian Infection and Immunity Network Lorne Infection and Immunity Conference in February 👏 @theviin.bsky.social @burnetinstitute.bsky.social @wehi-research.bsky.social

This study aims to assess health system needs for malaria elimination, identify national-level barriers to effective implementation, and provide recommendations for policymakers to strengthen strategies through a health system perspective.🔗https://shorturl.at/lz2h0

Our 2026 Travel Grants are officially open ✈️ 🧳 These awards are designed to support ACREME affiliated PhD students, Postdoctoral Researchers and Research Assistants/Officers to participate in training, lab exchanges, and field-based training. 🔗 acreme.edu.au/grants/trave...

MALARIA MILESTONE | New research published today in The Lancet Infectious Diseases, has confirmed the safety & effectiveness of high-dose primaquine & single-dose tafenoquine in G6PD-normal patients in treating P. vivax #malaria. Read more: tinyurl.com/mw7edaup @kthriemer.bsky.social

We’re excited to announce the launch of the 2026 Seed Grants 🎉 The program offers competitive research funding for pilot projects that fall within the three key research themes of ACREME MASTER-MAP. 🔗https://acreme.edu.au/grants/seed-grant/

We’re seeking an enthusiastic Early or Mid-Career Research Fellow to Chair the 2026 Annual Meeting Committee and contribute to ACREME Investigator Meetings 🗯️🌐 Applications close Friday 27 February. Apply now and help shape 2026: 🔗https://acreme.edu.au/what-we-do/opportunities/

This research aims to assess the effectiveness and safety of these new treatment options. 🔗 www.thelancet.com/journals/lan... #Malaria #MalariaElimination #EFFORTTrial

We’re pleased to announce the launch of our Regional Hub Travel and Training Grants for 2026, supporting collaboration, skills development, and research impact across our regional hubs.👉 acreme.edu.au/grants/trave... #ResearchFunding #GlobalHealth #Malaria #EndMalaria #AsiaPacific

These results highlight the urgent need for climate-resilient malaria control strategies and robust emergency response systems to safeguard progress towards malaria eradication. 🔗 www.nature.com/articles/s41...

This study shows that key parts of this system are shared across multiple malaria species and assemble in a similar way. Research also found that antibodies targeting this complex can block parasite invasion across species. www.nature.com/articles/s41...

We are proud to showcase our members who will be presenting their research at the 16th Lorne Infection and Immunity Conference 🔗 www.lorneinfectionimmunity.org

Burnet researchers Professor James Beeson, Dr Adam Thomas and Dr Herbert Opi have received the prestigious Grand Challenges Grant. The grant will support next-generation mRNA vaccine development for malaria control and elimination. Read more: www.burnet.edu.au/news/develop...

This research presents a mathematical model of RBC dynamics in response to malaria, which includes the spleen as an explicit compartment. 🔗 journals.plos.org/ploscompbiol... #Malaria #MalariaElimination

"Next-gen malaria vaccines have the potential to provide greater impact in preventing illness and death over the currently available vaccines..." @path.org www.path.org/our-impact/a...

Congrats to @rhea-longley.bsky.social on receiving NHMRC e-Asia 2025 funding. This work will apply serological markers to detect hidden Plasmodium vivax infections, strengthening both surveillance and intervention efforts 🎉👏 🔗 www.nhmrc.gov.au/about-us/new...